检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:魏松全[1] 梁荩忠[1] 李秀钧[1] 承永明[1] 梁正路[2] 李进前[2] 王全林 许淑惠[3]
机构地区:[1]华西医科大学附一院内分泌科 [2]华西医科大学附一院核医学科 [3]华西医科大学附一院检验科
出 处:《华西医学》1991年第3期258-261,共4页West China Medical Journal
摘 要:118例Graves病初发患者,用他巴唑治疗6月,停药后随访1年,51例缓解,67例复发。结果表明,治前的血清T_3、T_3/T_4比率及治疗结束时的T_3,在复发组与缓解组之间均有统计学差异(P<0.0005,0.005及0.025).而血清T_4,无论治前或治末,均无统计学差别(P>0.05).血清T_3/T_4比率是否与预后有关,其实质是取决于血清T_3,尤其是治前的血清T_3。118 new patients with Graves' disease were treated by methimazole for 6 months and follow-up for another 12 months. The initial dose was 30 mg/d. Bisochemical euthyroidism was achieved within 1-3 months after taking medicine and maintenance dose was given until cessation of the treatment. The results of 1 year follow-up after the withdrawal of drugs showed that of 118 patients, 67 had relapsed, with a recurrence rate of 56.8%, the remaining 51 (43.2%) were in remission. The serum T_3 before and at the end of treatment and T3/T4 ratio before therapy were significantly different between the groups of relapse and remission (p<0.0005, 0.025 and 0.005 respectively), but no significant difference in serum T3/T4 ratio at the end of therapy. The serum T3/T4 ratio is an unstable index and was affected by serum levels of T3 and T4, but serum T3 level before antithyroid drug therapy is a rather reliable parameter to predicting the outcome of hyperthyroidism due to Graves' disease
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.192